Kate Merritt

6PUBLICATIONS
61CO-AUTHORS
Psychiatry (incl. psychotherapy)Epigenetics (incl. genome methylation and epigenomics)Infant and child healthGene expression (incl. microarray and other genome-wide approaches)Biomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 17, 2025
PSYSCAN multi-centre study: baseline characteristics and clinical outcomes of the clinical high risk for psychosis sample.

Stefania Tognin, Sandra Vieira, Dominic Oliver

|Sep 12, 2024
Molecular and micro-architectural mapping of gray matter alterations in psychosis.

Natalia García-San-Martín, Richard A I Bethlehem, Agoston Mihalik

|Feb 22, 2023
Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis.

Kate Merritt, Robert A McCutcheon, André Aleman

|May 22, 2020
Glyceryl trinitrate in first-episode psychosis unmedicated with antipsychotics: A randomised controlled pilot study.

Kate Merritt, Ana Catalan, Samuel Cowley

|Aug 03, 2019
Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate.

Kate Merritt, Rocio Perez-Iglesias, Kyra-Verena Sendt

Pageof 1